Clinical trial • Other
Sugammadex for Neuromuscular blockade
Clinical trial of Sugammadex for Neuromuscular blockade. Randomised. 80 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Neuromuscular blockade
- Drug Modality
- Small molecule
Key dates
- Initial CTIS Submission Date
- 21-03-2025
- First CTIS Authorization Date
- 16-06-2025
Trial design
Randomised trial across 1 site in Hungary.
- Randomised
- Yes
- Target Sample Size
- 80
Eligibility
Recruits 80 No vulnerable population selected (isVulnerablePopulationSelected=false). Consent/assent handling not specified..
- Vulnerable Population
- No vulnerable population selected (isVulnerablePopulationSelected=false). Consent/assent handling not specified.
Recruitment
- Planned Sample Size
- 80
- Recruitment Window Months
- 45
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 80
Hungary
- Earliest CTIS Part Ii Submission Date
- 27-02-2025
- Latest Decision Or Authorization Date
- 16-06-2025
- Processing Time Days
- 109
- Number Of Sites
- 1
- Number Of Participants
- 80
Sites
- Site Name
- University Of Debrecen
- Department Name
- FACULTY OF MEDICINE Department of Anesthesiology and Intensive Care
- Principal Investigator Name
- László Asztalos
- Principal Investigator Email
- asztaloslasz@gmail.com
- Contact Person Name
- László Asztalos
- Contact Person Email
- asztaloslasz@gmail.com
Sponsor
Primary sponsor
- Full Name
- University Of Debrecen
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Hungary
Investigational products
- Investigational Product Name
- Sugammadex
- Active Substance
- Sugammadex
- Modality
- Small molecule
Related trials
Other published trials that may interest you.